Paediatric & Neonatal Testing Kits Market

Starting at US$ 5000

Buy Now
Companies
Market Size (2026)
USD 7.72 Bn
Forecast (2036)
USD 3.49 Bn
CAGR (2026 to 2036)
6.2%

Paediatric & Neonatal Testing Kits Market Size, Market Forecast and Outlook By FMI

The paediatric & neonatal testing kits market was valued at USD 4.0 billion in 2025. the market is set to reach USD 4.2 billion by 2026-end and grow at a CAGR of 6.2% between 2026-2036 to reach USD 7.7 billion by 2036. Assay Kits And Reagents will dominate with a 59.0% share, While Newborn Screening Panels will lead with a 40.0% share.

Summary of the Paediatric & Neonatal Testing Kits Market

  • Demand and Growth Drivers
    • Universal newborn screening program expansion is sustaining demand for neonatal testing kits used in metabolic, Endocrine, and genetic disorder detection.
    • Regulatory mandates for expanded newborn screening panels are creating compliance-driven procurement as health systems add conditions to mandatory testing protocols.
    • Point-of-care neonatal testing adoption in NICUs is expanding the market beyond centralized laboratory screening into bedside diagnostic applications.
  • Product and Segment View
    • Assay kits and reagents lead the product segment at 59.0%, reflecting recurring consumable procurement in newborn screening and neonatal diagnostic workflows.
    • Newborn screening panels account for 40.0% of the test type segment, driven by mandatory metabolic and endocrine disorder screening programs.
    • Hospital-based testing accounts for 53.0% of the application segment, with NICU diagnostics and newborn screening representing the primary procurement channels.
  • Geography and Competitive Outlook
    • The EU leads with a 6.4% CAGR, reflecting universal newborn screening mandates and expanded screening panel requirements across member states.
    • The UK at 6.3% CAGR sustains demand through NHS newborn screening program expansion and neonatal care investment.
    • Companies with validated screening assay portfolios and established hospital laboratory supply agreements are positioned for procurement growth.
  • Analyst Opinion
    • 'Companies with clinically validated neonatal screening panels covering expanded disorder lists are positioned to benefit as health systems add conditions to mandatory testing protocols.'
    • The market is expanding from standard metabolic screening toward comprehensive genetic and genomic neonatal testing.
    • Reimbursement coverage for expanded screening panels is a critical growth enabler across multiple healthcare systems.
    • Demand is supported by the global emphasis on early disease detection and neonatal health outcomes improvement.
Paediatric & Neonatal Testing Kits Market Value Analysis
Paediatric & Neonatal Testing Kits Market Value Analysis

Key Takeaways, Market Size, And Forecast

  • The paediatric & neonatal testing kits market was valued at USD 3.98 billion in 2025.
  • By 2036, The Paediatric & Neonatal Testing Kits Market is expected to be worth USD 7.72 billion.
  • From 2026 to 2036, The market is projected to expand at a CAGR of 6.2%.
  • The market is projected to create an incremental opportunity of USD 3.49 billion between 2026 and 2036.
  • In 2026, Assay kits and reagents is expected to account for 59% of the product segment, Driven by demand for established newborn screening workflows and high-volume consumable consumption in hospital and reference laboratory settings.
  • EU (6.4%) and UK (6.3%) are two of the fastest growing markets in the world.

Paediatric & Neonatal Testing Kits Market Definition

The paediatric and neonatal testing kits market encompasses diagnostic assay kits, Reagents, and consumables used in newborn screening, Neonatal intensive care diagnostics, and paediatric disease detection. Market scope includes metabolic screening panels, Immunoassay kits, Molecular diagnostic kits, and point-of-care neonatal testing products.

Paediatric & Neonatal Testing Kits Market Inclusions

Market scope includes all commercially traded paediatric and neonatal testing kits categorized by product (assay kits and reagents, Instruments, Controls), Test type (newborn screening panels, Metabolic, Immunoassay, Molecular), application (hospital-based, Reference laboratory, Point-of-care), Sample type, Condition category, and distribution channel. Revenue sizing covers the 2026 to 2036 forecast period.

Paediatric & Neonatal Testing Kits Market Exclusions

The scope does not include adult diagnostic kits, Paediatric imaging equipment, or neonatal monitoring devices without diagnostic testing functionality.

Paediatric & Neonatal Testing Kits Market Research Methodology

  • Primary Research: FMI analysts conducted interviews with manufacturers, Distributors, Procurement specialists, and end-use application experts in key markets.
  • Desk Research: Combined data from industry associations, regulatory filings, Certification bodies, and manufacturer disclosures.
  • Market Sizing and Forecasting: Bottom-up aggregation across product, Test type, application, end user, technology, Sample type, distribution channel segments, with regional adoption curves and cross-referencing against publicly available industry data.
  • Data Validation: Cross-checked quarterly against global production data, Trade statistics, and manufacturer-reported figures.

Why is the Paediatric & Neonatal Testing Kits Market Growing?

  • Structured demand for neonatal testing kits is being driven by regulatory mandates for expanded panels and the growth of universal newborn screening programs.
  • The market is moving from centralized laboratory screening applications to the use of point-of-care neonatal testing in NICUs.
  • The EU is driving growth at 6.4% CAGR with universal screening mandates and expanded panel requirements in member states.

The paediatric and neonatal testing kits market is expanding as universal newborn screening programs grow and regulatory mandates include more conditions in the list of mandatory tests. Newborn screening for early detection of metabolic, Endocrine and genetic disorders is a public health priority generating compliance driven procurement demand based on birth volumes and screening panel coverage.

Assay kits and reagents are leading at 59.0%. This is attributed to the recurring consumable procurement in screening and NICU diagnostic workflows. 40.0% of test type demand is driven by newborn screening panels because of mandatory metabolic disorder detection programs. Hospital testing accounts for 53.0% of applications, and the main procurement channels are centralized screening laboratories and point-of-care testing in NICUs.

Market Segmentation Analysis

  • Due to established supply and end-use preference, Assay Kits And Reagents is the dominant segment with a market share of 59% in the product segment.
  • Newborn Screening Panels is leading with 40% in the test type category.
  • Hospital Based Testing has the largest share in application segment.

The paediatric & neonatal testing kits market is segmented on the basis of product, Test type, application, end user, technology, Sample type, distribution channel. Each segment has different procurement criteria, end-use requirements and pricing structures.

Insights into the Product Segment

Paediatric & Neonatal Testing Kits Market Analysis By Product
Paediatric & Neonatal Testing Kits Market Analysis By Product

59% of the product segment is held by Assay Kits And Reagents. Demand is driven by the extent to which it can be used for end uses, the availability of supply chains and its cost competitiveness compared to alternatives.

Other products categories are: Metabolic Screening Kits, Newborn Heel Prick Tests, Enzyme Deficiency Tests, Catering to specific application requirements and showing diversity in technical specification across end-use industries.

Insights into the Test Type Segment

Paediatric & Neonatal Testing Kits Market Analysis By Test Type
Paediatric & Neonatal Testing Kits Market Analysis By Test Type

Newborn Screening Panels account for 40% of the test type segment. Demand is driven by the availability of end-use compatibility, Supply chain availability and cost competitiveness relative to other options.

Other test type categories include Metabolic Disorders Screening, PKU Testing, Thyroid Disorders, which satisfy specific application requirements and demonstrate variety of technical specifications across end-use industries.

Paediatric & Neonatal Testing Kits Market Drivers, Restraints, and Opportunities

  • Compliance-driven demand for neonatal testing kits tied to birth volumes and increasing screening panel requirements are generating universal newborn screening mandates.
  • Some regions are constrained by the healthcare budget for the rate of expansion of the screening panels and testing kits.
  • NICUs are expanding the addressable market beyond centralized lab screening with point-of-care neonatal diagnostics.

Regulatory imperatives, Cost structure limitations and budding application prospects are shaping the paediatric & neonatal testing kits market. Different segments, Geographies and the price sensitivity of end-use applications adopt at different speeds.

Screening Program Expansion

Across the globe, Health systems are increasing the number of conditions in their newborn screening panels, including more metabolic, Endocrine, and genetic conditions. Any further condition requires new assay kits, which creates a commensurate demand for procurement that is dependent on regulatory decisions.

Healthcare Budget Constraints

The expansion rate of the screening panel in cost-constrained healthcare systems is limited by budget allocation decisions and reimbursement coverage. Markets with universal healthcare funding already in place move faster.

NICU Point-of-Care Testing

The advent of bedside diagnostic testing in neonatal intensive care units is creating a new procurement demand for rapid turnaround assay kits. Products for point-of-care testing in NICUs need to offer simplified workflows and validated performance at low sample volumes.

Analysis of Paediatric & Neonatal Testing Kits Market By Key Countries

Top Country Growth Comparison Paediatric & Neonatal Testing Kits Market Cagr (2026 2036)
Top Country Growth Comparison Paediatric & Neonatal Testing Kits Market Cagr (2026 2036)
Country CAGR
EU 6.4%
UK 6.3%
South Korea 6.2%
USA 6%
  • EU leads with a 6.4% CAGR, reflecting EU regulatory frameworks.
  • UK at 6.3% shows strong demand due to regulatory alignment with quality standards and established distribution infrastructure.
  • South Korea (6.2%) and USA (6%) continue growing, Supported by end-use industry expansion.

The global paediatric & neonatal testing kits market is expected to grow at a rate of 6.2% per year from 2026 to 2036. the study covers more than 30 countries, and the main markets are listed below.

Demand Outlook for Paediatric & Neonatal Testing Kits Market in Europe

Paediatric & Neonatal Testing Kits Market Europe Country Market Share Analysis, 2026 & 2036
Paediatric & Neonatal Testing Kits Market Europe Country Market Share Analysis, 2026 & 2036

Europe is projected to grow at a rate of 6.4% through 2036, reflecting EU regulatory frameworks, sustainability mandates, and advanced manufacturing infrastructure. Demand is supported by EU-wide regulatory harmonization, sustainability mandates, and advanced manufacturing infrastructure.

  • EU regulatory frameworks are creating compliance-LED demand across member states.
  • Sustainability mandates are accelerating adoption of compliant product specifications.
  • Advanced manufacturing infrastructure supports efficient production and distribution.

Future Outlook for Paediatric & Neonatal Testing Kits Market in UK

UK is expected to grow 6.3% through 2036 mirroring regulatory alignment to quality standards and existing distribution infrastructure. regulatory alignment, established distribution channels and quality-driven procurement are supporting demand.

  • Regulatory standards are influencing product specifications and acquisition criteria.
  • Built out distribution infrastructure to efficiently cover the market throughout the region.
  • The demand in the premium segment is creating opportunities for value-added product positioning.

Opportunity Analysis of Paediatric & Neonatal Testing Kits Market in South Korea

South Korea is projected to achieve a growth rate of 6.2 percent through 2036, driven by technology-LED adoption, modernization of the manufacturing sector and export-oriented production capabilities. Investment in manufacturing, technology adoption and export-oriented capabilities are supporting demand.

  • Technology-LED adoption is fueling procurement modernization in industrial applications.
  • Investment in manufacturing sector contributes to domestic demand and export competitiveness.
  • Development of regulatory requirements are raising product specification requirements across categories.

In-depth Analysis of Paediatric & Neonatal Testing Kits Market in USA

Paediatric & Neonatal Testing Kits Market Country Value Analysis
Paediatric & Neonatal Testing Kits Market Country Value Analysis

USA is expected to grow at 6% till 2036, Propelled by established procurement networks, Investment in regulatory compliance and strong demand from end use. Demand is supported by compliance-driven buying, Existing distribution networks and a demand for premium products.

  • Regulatory-compliant procurement is sustaining demand for products that meet specifications.
  • Efficient supply chain coverage across end-use sectors is enabled by established distribution networks.
  • Premium product demand is creating value-added procurement channels in addition to volume buying.

Competitive Landscape and Strategic Positioning

Paediatric & Neonatal Testing Kits Market Analysis By Company
Paediatric & Neonatal Testing Kits Market Analysis By Company
  • PerkinElmer Inc. holds a leading position owing to established manufacturing infrastructure, Broad product portfolio, and strong end-use customer relationships.
  • Bio-Rad Laboratories, Inc. and Abbott Laboratories maintain competitive positions through product breadth and regional distribution capabilities.
  • Smaller and emerging players are focusing on specialized applications and niche segments to build market position.

PerkinElmer Inc. is a leading participant owing to broad manufacturing capacity and established relationships with end-use customers across multiple geographies. Bio-Rad Laboratories, Inc. competes through product portfolio breadth and distribution reach.

Abbott Laboratories and Thermo Fisher Scientific Inc. maintain competitive positions in specific product categories and regional markets. Barriers to entry include manufacturing scale requirements, regulatory certification timelines, and established procurement relationships.

Strategic priorities include cost optimization, Geographic expansion, product specification upgrades, and alignment with regulatory compliance timelines.

Key Companies in the Paediatric & Neonatal Testing Kits Market

Key global companies leading the paediatric & neonatal testing kits market include:

  • PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories hold leading positions through established infrastructure and strong customer relationships.
  • Thermo Fisher Scientific Inc. and Danaher Corporation maintain competitive positions through regional expertise and product specialization.

Competitive Benchmarking: Paediatric & Neonatal Testing Kits Market

Company Screening Panel Breadth Clinical Validation Hospital Lab Access Geographic Reach
PerkinElmer Inc. High Strong Strong Global
Bio-Rad Laboratories, Inc. High Strong Strong Global
Abbott Laboratories High Strong Strong Global
Thermo Fisher Scientific Inc. Medium Moderate Moderate Regional
Danaher Corporation Medium Moderate Moderate Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Paediatric & Neonatal Testing Kits Market

  • In 2025, Revvity (formerly PerkinElmer Inc.) continued to support expanded newborn screening programs through its established platforms (e.g., EONIS, QSight) and genomics initiatives, including participation in studies and sequencing services aligned with growing EU and global mandates for genetic disorder detection (no major new panel expansion with additional assays was specifically launched in 2025).
  • In 2025, Abbott Laboratories continued to advance its point-of-care testing portfolio suitable for neonatal and NICU settings, with emphasis on low-sample-volume capabilities through systems such as i-STAT (no new dedicated rapid neonatal point-of-care testing platform was introduced specifically for bedside NICU diagnostics).

Key Players in the Paediatric & Neonatal Testing Kits Market

Major Global Players

  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation

Emerging Players/Startups

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation

Report Scope and Coverage

Paediatric & Neonatal Testing Kits Market Breakdown By Product, Test Type, And Region
Paediatric & Neonatal Testing Kits Market Breakdown By Product, Test Type, And Region
Quantitative Units USD 4.23 billion to USD 7.72 billion, at a CAGR of 6.2%
Market Definition The paediatric & neonatal testing kits market encompasses products categorized by product, Test type, application, end user, technology, Sample type, distribution channel across all major end-use applications.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered EU, UK, South Korea, USA, 30 plus countries
Key Companies Profiled PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation
Forecast Period 2026 to 2036
Approach Hybrid bottom-up and top-down methodology starting with verified transaction data, Projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Paediatric & Neonatal Testing Kits Market Segmented by Product:

  • Assay Kits And Reagents
    • Metabolic Screening Kits
      • Newborn Heel Prick Tests
      • Enzyme Deficiency Tests
  • Genetic Testing Kits
    • DNA Based Assays
      • Congenital Disorder Screening
      • Inherited Disease Panels
  • Infectious Disease Testing Kits
    • Rapid Diagnostic Kits
      • Neonatal Sepsis Testing
      • Viral Infection Detection
  • Consumables
    • Sample Collection Devices
      • Dried Blood Spot Cards
      • Swabs And Tubes
  • Instruments
    • Mass Spectrometry Systems
      • Tandem MS Systems
      • Metabolic Analysis
  • PCR And Molecular Systems
    • Real Time PCR Systems
      • Genetic Analysis
  • Point Of Care Devices
    • Bedside Testing Devices
      • Portable Diagnostics

Paediatric & Neonatal Testing Kits Market Segmented by Test Type:

  • Newborn Screening Panels
    • Metabolic Disorders Screening
      • PKU Testing
      • Thyroid Disorders
  • Genetic Screening
    • Chromosomal Abnormality Testing
      • Down Syndrome Screening
      • Rare Genetic Disorders
  • Infectious Disease Testing
    • Bacterial Infection Screening
      • Viral Panels
      • Sepsis Detection
  • Hearing Screening
    • Audiology Tests
      • Otoacoustic Emissions
      • Neonatal Hearing Tests
  • Critical Congenital Heart Defect Screening
    • Pulse Oximetry Based Testing
      • Cardiac Anomaly Detection
  • Others
    • Bilirubin Testing
      • Jaundice Monitoring

Paediatric & Neonatal Testing Kits Market Segmented by Application:

  • Hospital Based Testing
    • NICU Diagnostics
      • Neonatal Intensive Care Monitoring
      • Emergency Neonatal Care
  • Diagnostic Laboratories
    • Centralized Testing Labs
      • High Throughput Screening
  • Maternity Clinics
    • Birth Based Screening
      • Early Detection Programs
  • Point Of Care Testing
    • Bedside Diagnostics
      • Rapid Screening Kits

Paediatric & Neonatal Testing Kits Market Segmented by End User:

  • Hospitals
    • NICU And PICU Units
      • Specialized Neonatal Care
      • Emergency Units
  • Diagnostic Laboratories
    • Reference Laboratories
      • National Screening Programs
  • Maternity And Specialty Clinics
    • Birth Centers
      • Prenatal And Postnatal Care
  • Point Of Care Settings
    • Community Health Centers
      • Rural Screening Programs
  • Research Institutes
    • Clinical Research
      • Pediatric Studies

Paediatric & Neonatal Testing Kits Market Segmented by Technology:

  • Molecular Diagnostics
    • PCR Based Testing
      • Real Time PCR
      • Genetic Sequencing
  • Mass Spectrometry
    • Tandem MS MS
      • Metabolic Disorder Detection
  • Immunoassays
    • Enzyme Linked Assays
      • Biomarker Detection
  • Biosensor Based Testing
    • Portable Sensors
      • Rapid Diagnostics

Paediatric & Neonatal Testing Kits Market Segmented by Sample Type:

  • Blood Based Testing
    • Dried Blood Spot
      • Heel Prick Samples
      • Metabolic Screening
  • Urine Based Testing
    • Biochemical Analysis
      • Metabolic Disorders
  • Saliva Based Testing
    • Non Invasive Sampling
      • Genetic Screening

Paediatric & Neonatal Testing Kits Market Segmented by Distribution Channel:

  • Direct Sales
    • Hospital Procurement
      • Bulk Institutional Supply
      • Government Contracts
  • Distributors And Suppliers
    • Diagnostic Distributors
      • Regional Supply Chains
  • Online Sales
    • B2B Procurement Platforms
      • Medical E Commerce

Paediatric & Neonatal Testing Kits Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • World Health Organization. (2025). Global Newborn Screening and Neonatal Health Report. WHO.
  • European Commission. (2024). EU Recommendation on Newborn Screening Programs. EC.
  • United States Health Resources and Services Administration. (2025). Recommended Uniform Screening Panel (RUSP) Update. HRSA.
  • International Society for Neonatal Screening. (2025). Global Newborn Screening Standards and Practices. ISNS.
  • American College of Medical Genetics. (2024). Newborn Screening Condition Assessment Report. ACMG.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the paediatric & neonatal testing kits market and revenue projections from 2026 to 2036.
  • Segmentation by product, Test type, application, end user, technology, Sample type, distribution channel.
  • Insights across more than 30 country and regional markets.
  • Analysis of key growth drivers, Restraints, and emerging opportunities.
  • Assessment of the competitive landscape and strategic positioning.
  • Identification of investment opportunities across primary application segments.
  • Supply chain structure and distribution channel analysis.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

What is the global market demand for Paediatric & Neonatal Testing Kits Market in 2026?

In 2026, the global paediatric & neonatal testing kits market is expected to be worth USD 4.23 billion.

How big will the Paediatric & Neonatal Testing Kits Market be in 2036?

By 2036, the paediatric & neonatal testing kits market is expected to be worth USD 7.72 billion.

How much is demand for Paediatric & Neonatal Testing Kits Market expected to grow between 2026 and 2036?

Between 2026 and 2036, the paediatric & neonatal testing kits market is expected to grow at a CAGR of 6.2%.

Which segment is likely to lead the Paediatric & Neonatal Testing Kits Market in 2026?

In the Paediatric & Neonatal Testing Kits Market, Assay Kits And Reagents is expected to account for 59% of the product segment in 2026, reflecting strong downstream demand and established procurement patterns.

What is causing demand to rise in EU for the Paediatric & Neonatal Testing Kits Market?

In the Paediatric & Neonatal Testing Kits Market, EU is projected to grow at 6.4% through 2036, reflecting EU regulatory frameworks, sustainability mandates, and advanced manufacturing infrastructure.

What is causing demand to rise in UK for the Paediatric & Neonatal Testing Kits Market?

In the Paediatric & Neonatal Testing Kits Market, UK is projected to grow at 6.3% through 2036, reflecting regulatory alignment with quality standards and established distribution infrastructure.

What is the definition of the Paediatric & Neonatal Testing Kits Market?

The paediatric & neonatal testing kits market encompasses products categorized by product, Test type, application, end user, technology, Sample type, distribution channel across all major end-use applications.

How does FMI forecast and validate the Paediatric & Neonatal Testing Kits Market?

Forecasting models use a hybrid bottom-up and top-down approach, starting with verified transaction data and cross-referencing against global production statistics and manufacturer disclosures.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Paediatric & Neonatal Testing Kits Market